Dyspnoea during treadmill walking Borg scale at isotime during constant work rate treadmill test Scale ranges from 0 to 10, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in dyspnoea score · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life (Change in CRQ Dyspnoea) CRQ · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Six‐minute walk distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life Dyspnoea domain of Hiratsuka scale Scores range from 0 to 100, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in dyspnoea score · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in 6‐minute walking distance · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life Change in total score of St George Respiratory Questionnaire · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnoea during exercise Modified Borg dyspnoea score at end of 6‐minute walk test Scores range from 0 to 10, with lower scores indicating less shortness of breath · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnea · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
Need for increased ventilatory assistance (invasive or non‐invasive) · individuals with an exacerbation of COPD
The intervention may leads to lower need for increased ventilatory assistance (invasive or non‐invasive) (low certainty).
1 finding from 1 review
Intervention not reported
Duration of ventilatory assistance days · individuals with an exacerbation of COPD
1 finding from 1 review
Intervention not reported
Length of hospital stay days · individuals with an exacerbation of COPD
1 finding from 1 review
SGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
1 finding from 1 review
Hospitalisations, number of participants with 1 or more exacerbations · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
Tiotropium probably leads to lower patients with 1 or more exacerbations compared with long‐acting beta‐agonists (moderate certainty).
1 finding from 1 review
Mortality (all‐cause) · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
It is very uncertain whether tiotropium changes mortality (all‐cause) compared with long‐acting beta‐agonists (very low certainty).
1 finding from 1 review
Cost‐effectiveness · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
1 finding from 1 review
no estimate extracted
6 participants
Low
Hospital admissions · patients with acute asthma
IV + inhaled beta agonist showed no clear difference in admissions to hospital compared with inhaled beta‐agonist (low certainty).
1 finding from 1 review
Healthcare use: length of stay in the emergency department · patients with acute asthma
IV + inhaled beta agonist showed no clear difference in length of stay in emergency department compared with inhaled beta‐agonist (moderate certainty).
1 finding from 1 review